10-Q Filing

TRANSMEDICS GROUP, INC. CIK: 1756262 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001564590-20-051966`
Period End Date	20200930
Filing Date	20201106
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	tmdx-20200930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 73 Income Statement 66 Cash Flow Statement 78 Stockholders Equity 61 Comprehensive Income 31

Balance Sheet 73 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$20.09M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$20.41M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$21.40M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$60.60M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$111.32M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Common Stock, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$6.14M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$6.56M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Inventory	`InventoryNet`	$12.98M	USD	Point-in-time
Inventory	`InventoryNet`	$11.22M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	27.16M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.29M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.54M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	21.18M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	21.18M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$154.13M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$100.00M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	27.16M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.79M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.69M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$6.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$6.00K	USD	Point-in-time
Total assets	`Assets`	$159.32M	USD	Point-in-time
Total assets	`Assets`	$105.30M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.25M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$778.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$8.33M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$11.47M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$1.35M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$166.00K	USD	Point-in-time
Current portion of deferred rent	`DeferredRentCreditCurrent`	$370.00K	USD	Point-in-time
Current portion of deferred rent	`DeferredRentCreditCurrent`	$25.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$13.62M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$16.11M	USD	Point-in-time
Long-term debt, net of discount and current portion	`LongTermDebtNoncurrent`	$34.15M	USD	Point-in-time
Long-term debt, net of discount and current portion	`LongTermDebtNoncurrent`	$34.52M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.62M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$389.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$50.65M	USD	Point-in-time
Total liabilities	`Liabilities`	$49.77M	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, no par value; 150,000,000 shares authorized; 27,159,065 shares and 21,184,524 shares issued and outstanding at September 30, 2020 and December 28, 2019, respectively	`CommonStockValue`	$424.13M	USD	Point-in-time
Common stock, no par value; 150,000,000 shares authorized; 27,159,065 shares and 21,184,524 shares issued and outstanding at September 30, 2020 and December 28, 2019, respectively	`CommonStockValue`	$501.49M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-16.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-391.92M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-369.48M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$63.47M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$109.55M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-192.24M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-199.04M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$54.65M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$71.16M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$46.68M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$113.76M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$159.32M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$105.30M	USD	Point-in-time

Income Statement 66 line items

Line Item	Tag	Value	Unit	Period
Net revenue	`Revenues`	$7.21M	USD	1 Quarter
Net revenue	`Revenues`	$7.09M	USD	1 Quarter
Net revenue	`Revenues`	$17.55M	USD	3 Qtrs
Net revenue	`Revenues`	$18.01M	USD	3 Qtrs
Cost of revenue	`CostOfRevenue`	$2.99M	USD	1 Quarter
Cost of revenue	`CostOfRevenue`	$7.42M	USD	3 Qtrs
Cost of revenue	`CostOfRevenue`	$6.21M	USD	3 Qtrs
Cost of revenue	`CostOfRevenue`	$2.05M	USD	1 Quarter
Gross profit	`GrossProfit`	$11.81M	USD	3 Qtrs
Gross profit	`GrossProfit`	$5.04M	USD	1 Quarter
Gross profit	`GrossProfit`	$4.22M	USD	1 Quarter
Gross profit	`GrossProfit`	$10.12M	USD	3 Qtrs
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$14.28M	USD	3 Qtrs
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$4.94M	USD	1 Quarter
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$4.16M	USD	1 Quarter
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$13.61M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$18.01M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$5.49M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$17.42M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$6.52M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$31.03M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$11.46M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$9.65M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$32.30M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-20.91M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-4.61M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-7.24M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-20.49M	USD	3 Qtrs
Interest expense	`InterestExpense`	$3.29M	USD	3 Qtrs
Interest expense	`InterestExpense`	$3.01M	USD	3 Qtrs
Interest expense	`InterestExpense`	$971.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.08M	USD	1 Quarter
Change in fair value of preferred stock warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of preferred stock warrant liability	`FairValueAdjustmentOfWarrants`	$341.00K	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$200.00K	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$1.09M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$499.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$56.00K	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-3.43M	USD	3 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-472.00K	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-1.93M	USD	3 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-1.03M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-24.34M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-5.08M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-22.41M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-8.27M	USD	1 Quarter
Provision for income taxes	`CurrentIncomeTaxExpenseBenefit`	$10.00K	USD	1 Quarter
Provision for income taxes	`CurrentIncomeTaxExpenseBenefit`	$6.00K	USD	1 Quarter
Provision for income taxes	`CurrentIncomeTaxExpenseBenefit`	$30.00K	USD	3 Qtrs
Provision for income taxes	`CurrentIncomeTaxExpenseBenefit`	$22.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-6.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.50M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.44M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-8.28M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.09M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-24.37M	USD	3 Qtrs
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.19	USD	1 Quarter
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.94	USD	3 Qtrs
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-2.05	USD	3 Qtrs
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.39	USD	1 Quarter
Weighted average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	21.13M	shares	1 Quarter
Weighted average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	11.88M	shares	3 Qtrs
Weighted average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	27.16M	shares	1 Quarter
Weighted average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	23.89M	shares	3 Qtrs

Cash Flow Statement 78 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-22.44M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-33.50M	USD	Annual
Net loss	`ProfitLoss`	$-24.37M	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$866.00K	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$1.15M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$1.72M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$572.00K	USD	3 Qtrs
Change in fair value of preferred stock warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of preferred stock warrant liability	`FairValueAdjustmentOfWarrants`	$341.00K	USD	3 Qtrs
Non-cash interest expense and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$352.00K	USD	3 Qtrs
Non-cash interest expense and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$379.00K	USD	3 Qtrs
Net amortization (accretion) of premiums (discounts) on marketable securities	`AmortizationOfDebtDiscountPremium`	$304.00K	USD	3 Qtrs
Net amortization (accretion) of premiums (discounts) on marketable securities	`AmortizationOfDebtDiscountPremium`	$-136.00K	USD	3 Qtrs
Unrealized foreign currency transaction (gains) losses	`ForeignCurrencyTransactionGainLossUnrealized`	$523.00K	USD	3 Qtrs
Unrealized foreign currency transaction (gains) losses	`ForeignCurrencyTransactionGainLossUnrealized`	$-392.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$3.10M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-472.00K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$3.24M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$2.40M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$314.00K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$736.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.05M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-6.42M	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$3.32M	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$2.95M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-136.00K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$1.16M	USD	3 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$-889.00K	USD	3 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$261.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-25.02M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-23.13M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$453.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$184.00K	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$101.51M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$67.68M	USD	3 Qtrs
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$50.48M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-67.86M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-51.48M	USD	3 Qtrs
Payments of public offering costs and other financing costs	`PaymentsOfStockIssuanceCosts`	$705.00K	USD	3 Qtrs
Payments of public offering costs and other financing costs	`PaymentsOfStockIssuanceCosts`	$4.51M	USD	3 Qtrs
Proceeds from issuance of common stock in public offering, net of underwriting discounts and commissions	`ProceedsFromIssuanceOfCommonStockInInitialPublicOfferingNetOfUnderwritingDiscountsAndCommissions`	$97.37M	USD	3 Qtrs
Proceeds from issuance of common stock in public offering, net of underwriting discounts and commissions	`ProceedsFromIssuanceOfCommonStockInInitialPublicOfferingNetOfUnderwritingDiscountsAndCommissions`	$75.67M	USD	3 Qtrs
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$194.00K	USD	3 Qtrs
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$108.00K	USD	3 Qtrs
Proceeds from issuance of common stock in connection with employee stock purchase plan	`ProceedsFromStockPlans`	$357.00K	USD	3 Qtrs
Proceeds from Paycheck Protection Program loan	`ProceedsFromPaycheckProtectionProgramLoan`	$2.25M	USD	3 Qtrs
Repayment of Paycheck Protection Program loan	`RepaymentOfPaycheckProtectionProgramLoan`	$2.25M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$92.97M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$75.52M	USD	3 Qtrs
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$80.00K	USD	3 Qtrs
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$398.00K	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.30M	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$166.00K	USD	3 Qtrs
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.91M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.59M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.74M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$21.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.91M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.59M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.74M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$21.90M	USD	Point-in-time
Conversion of convertible preferred stock to common stock upon initial public offering	`ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering`	$186.52M	USD	3 Qtrs
Settlement of accrued financing fee	`SettlementOfAccruedFinancingFee`	$124.00K	USD	3 Qtrs
Transfers of inventory to property and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$705.00K	USD	3 Qtrs
Transfers of inventory to property and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$1.90M	USD	3 Qtrs
Reclassification of warrants to additional paid-in capital	`ReclassificationOfWarrantsToAdditionalPaidInCapital`	$1.24M	USD	3 Qtrs
Purchases of property and equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$26.00K	USD	3 Qtrs
Purchases of property and equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$90.00K	USD	3 Qtrs
Offering costs included in accounts payable and accrued expenses	`DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses`	$120.00K	USD	3 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$20.09M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$20.41M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$21.40M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.91M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.59M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.74M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$21.90M	USD	Point-in-time

Stockholders Equity 61 line items

Line Item	Tag	Value	Unit	Period
Discounts and issuance costs of stock issued	`DiscountsAndStockIssuanceCosts`	$5.97M	USD	1 Quarter
Discounts and issuance costs of stock issued	`DiscountsAndStockIssuanceCosts`	$628.00K	USD	1 Quarter
Balance	`StockholdersEquity`	$63.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$109.55M	USD	Point-in-time
Balance	`StockholdersEquity`	$-192.24M	USD	Point-in-time
Balance	`StockholdersEquity`	$-199.04M	USD	Point-in-time
Balance	`StockholdersEquity`	$54.65M	USD	Point-in-time
Balance	`StockholdersEquity`	$71.16M	USD	Point-in-time
Balance	`StockholdersEquity`	$46.68M	USD	Point-in-time
Balance	`StockholdersEquity`	$113.76M	USD	Point-in-time
Conversion of convertible preferred stock into common stock upon initial public offering	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$186.52M	USD	1 Quarter
Conversion of preferred stock warrants into common stock warrants upon initial public offering	`ConversionOfPreferredStockWarrantsIntoCommonStockWarrantsUponInitialPublicOffering`	$1.24M	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$27.00K	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$8.00K	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$94.00K	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.00K	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$75.00K	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$92.00K	USD	1 Quarter
Issuance of common stock in initial public offering,net of discounts and issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$91.40M	USD	1 Quarter
Issuance of common stock in initial public offering,net of discounts and issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$75.04M	USD	1 Quarter
Settlement of accruedfinancing fee	`StockIssuedDuringPeriodValueSettlementOfAccruedFinancingFee`	$124.00K	USD	1 Quarter
Issuance of common stock in connection with employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$197.00K	USD	1 Quarter
Issuance of common stock in connection with employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$160.00K	USD	1 Quarter
Reversal of estimated offering costs	`ReversalOfEstimatedOfferingCosts`	$43.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$631.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$57.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$220.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$700.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$295.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$385.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-42.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-10.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$69.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$56.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$34.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-21.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$52.00K	USD	3 Qtrs
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$22.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-68.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-4.00K	USD	3 Qtrs
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$213.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-149.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$30.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.50M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.44M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-8.28M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.09M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-24.37M	USD	3 Qtrs
Balance	`StockholdersEquity`	$63.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$109.55M	USD	Point-in-time
Balance	`StockholdersEquity`	$-192.24M	USD	Point-in-time
Balance	`StockholdersEquity`	$-199.04M	USD	Point-in-time
Balance	`StockholdersEquity`	$54.65M	USD	Point-in-time
Balance	`StockholdersEquity`	$71.16M	USD	Point-in-time
Balance	`StockholdersEquity`	$46.68M	USD	Point-in-time
Balance	`StockholdersEquity`	$113.76M	USD	Point-in-time

Comprehensive Income 31 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-6.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.50M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.44M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-8.28M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.09M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-24.37M	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-42.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-10.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$69.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$56.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$34.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-21.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$52.00K	USD	3 Qtrs
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$22.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-68.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-4.00K	USD	3 Qtrs
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$213.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-149.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$30.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$78.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-52.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-14.00K	USD	3 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$121.00K	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-8.20M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-22.45M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-5.14M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-24.25M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.